Anti-Human KLRB1 Monoclonal Antibodies and Uses Thereof
Invention type: Technology
/
Case number: #21645J
The present disclosure relates to, inter alia, compounds (e.g., antibodies, or antigen-binding fragments thereof) that bind to an epitope of CD161 an inhibit the interaction between CD161 and CLEC2D, and the use of the compounds in methods for treating, or ameliorating one or more symptoms of, cancer.
Researchers
Kai Wucherpfennig
/ Byong Ha Kang
/ Nathan Mathewson
/ Karl Wittrup
Departments: Department of Chemical Engineering
Technology Areas: Drug Discovery and Research Tools: Antibodies / Therapeutics: Proteins & Antibodies
Impact Areas: Healthy Living
-
monoclonal antibodies that bind human cd161
United States of America | Granted | 11,459,389
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.